Clinical Trial

Long-term Observational Study of Patients Treated With Inaticabtagene Autoleucel Injection

Recruiting
View on ClinicalTrials.gov →
Summary
This clinical trial adopts an observational research method to conduct annual follow-up and monitoring of patients receiving treatment with Inaticabtagene Autoleucel Injection after its commercialization, in order to evaluate the delayed adverse events of Inaticabtagene Autoleucel Injection.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2024-06-12.
Status change: Active, Not Recruiting → Recruiting 2025-08-06
Trial Details
NCT Number NCT06461351
Lead Sponsor Juventas Cell Therapy Ltd.
Conditions B-cell Tumors
Enrollment 1,000 participants
Start Date 2024-03-30
Primary Completion 2039-05-30 (estimated)
Study Completion 2040-03-30 (estimated)
Updated on ClinicalTrials.gov 2025-08-07